Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CNMD · against 449 other Healthcare companies of similar size
Ranked #217 of 450 · scores higher than 51% of peers
Bars: peers in each 10-point band of the profitability score56 peers with a profitability score of 50–59, including CNMD · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | CNMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 425 reported | 4.7% | 5.4% | 48% | 33% | |
| Operating marginHigher is better · 424 reported | 8.0% | 7.1% | 53% | 33% | |
| Return on assetsHigher is better · 436 reported | 2.5% | 1.9% | 57% | 33% | |
| Return on equityHigher is better · 420 reported | 5.5% | 3.4% | 57% | Context only | |
| Gross marginHigher is better · 466 reported | 55.6% | 48.1% | 60% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 217 | 13.3B CNY (≈$1.9B) | 52 | 65 | |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 217 |
| 11.4B CNY (≈$1.6B) |
| 52 |
| 51 |
| 217 | 10.2B CNY (≈$1.4B) | 52 | 55 |
| 217 | 193.1B JPY (≈$1.3B) | 52 | 48 |
| 217 | 1.4B USD | 52 | 42 |
| 217 | 148.7B INR (≈$1.8B) | 52 | 48 |
| 223 | 7.1B CNY (≈$998M) | 51 | 56 |
| 223 | 5.1B CNY (≈$714M) | 51 | 45 |
| 223 | 5.8B CNY (≈$816M) | 51 | 45 |